Opportunity status:
Open
Funders:
Medical Research Council (MRC)
Co-funders:
UK Human Functional Genomics Initiative
Funding type:
Grant
Award range:
£15,000 - £100,000
Publication date:
20 July 2026
Opening date:
1 April 2026 9:00am UK time
Closing date:
1 November 2026 11:59pm UK time
Apply for an Academic and Industry Partnership award as part of the UK Human Functional Genomics Initiative’s (FGx) Innovation and Collaboration fund. The awards will enable the development of links between industrial partners and the FGx.
These awards can be used to support feasibility, pilot or initial studies to provide preliminary experiments to explore ideas and generate initial data which could support the development of competitive collaborative grant proposals for longer term projects.
You must be based at a UK research organisation to be eligible for this funding.
Scope
The projects should build and strengthen collaborations across the Initiative and the UK through feasibility, pilot or initial studies to provide preliminary experiments to explore ideas and generate initial data which could support the development of competitive collaborative grant proposals for longer term projects.
Areas of potential interest include (but are not limited to):
Technology priming projects that support the initiative, functional genomics screening lab or a specific research cluster are welcome.
Projects that offer to bring in specific knowledge or contributions to the initiative are encouraged.
What we will fund
This grant may be used to support the following:
What we will not fund
This grant may not be used to support:
Matched funding
Industrial partners will be expected to provide matched funding (cash, in-kind or both).
Start date
Projects should start within three months of being awarded.
This is the most important predictor.
Competitive proposals closely match:
A scientifically excellent proposal that does not fit the published scope is unlikely to be funded.
UKRI evaluates whether the research:
Reviewers assess the originality, significance, and quality of the proposed research.
Competitive proposals typically demonstrate:
UKRI supports both curiosity-driven discovery research and innovative applied research, depending on the funding opportunity.
Applications should provide:
Reviewers expect a convincing plan for delivering the proposed work.
UKRI's assessment framework places strong emphasis on the ability of the applicant and team to deliver the project.
Competitive teams demonstrate:
For early-career schemes, reviewers evaluate potential rather than only past achievements.
Reviewers consider whether the research environment provides:
The host organization should clearly demonstrate its ability to support successful project delivery.
Although UKRI has moved away from the separate "Pathways to Impact" document, proposals are still expected to explain how the research could generate benefits.
Competitive applications describe potential impacts such as:
The expected impact should be appropriate to the research stage and funding opportunity.
UKRI increasingly encourages interdisciplinary research.
Competitive projects often involve:
Cross-sector collaboration is especially important for large strategic and challenge-led programs.
UKRI expects applicants to consider:
These considerations strengthen the overall quality and credibility of the proposal.
Reviewers assess whether:
Strong justification of resources is an important component of UKRI review.
To lead a project, you must be based at an eligible organisation. Check if your organisation is eligible.
You must be a researcher eligible for Medical Research Council (MRC) funding. You can apply as an independent researcher with collaboration from an industrial partner.
You do not need to be MRC funded to apply.
Eligible Countries:
Sponsor Institute/Organizations: UK Research and Innovation
Sponsor Type: Corporate/Non-Profit
Address: Polaris House, North Star Avenue, Swindon SN2 1FL
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Nov 06, 2026
Nov 06, 2026
$17,087
up to £100,000
Affiliation: UK Research and Innovation
Address: Polaris House, North Star Avenue, Swindon SN2 1FL
Website URL: https://www.ukri.org/opportunity/collaborate-with-the-uk-human-functional-genomics-initiative/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.